Core Insights - Guizhou Mingtai Biotechnology Co., Ltd. (Utide) received two prestigious awards at the 2025 Brand Strong Country Economic Forum for its contributions in the field of peptide drug research and industrialization [1] - The company’s general manager, Wang Renyou, was recognized as one of the "Top Ten Leaders in the Health Peptide Drug Industry" [1] - The awards were organized by China Business News and China Business Magazine, aimed at recognizing enterprises and leaders that drive industrial upgrades and technological innovation [1] Company Overview - Guizhou Mingtai Biotechnology is located in the Zunyi City Health Industry Park and specializes in the research, production, and sales of peptide raw materials [1] - The company has rapidly become a key player in the global supply chain for related drugs, particularly in the GLP-1 series of peptide raw materials, with products exported to North America, Europe, and Southeast Asia [1] Future Focus - The company aims to continue focusing on breakthroughs in core peptide raw material technologies and will enhance drug efficacy while reducing production costs through deep integration of industry, academia, and research [2]
斩获2025品牌强国三项大奖
Xin Lang Cai Jing·2026-02-02 22:12